{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:51:54Z","timestamp":1785513114033,"version":"3.56.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To highlight recent findings on pathogenic mechanisms and clinical associations which characterize the role of infectious agents as triggers for Sj\u00f6gren's syndrome development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Several candidate infectious agents have been identified to induce the autoimmune and inflammatory pathways leading to Sj\u00f6gren's syndrome clinical appearance in the setting of a genetic background. This is reinforced by the demonstration that Sj\u00f6gren's syndrome patients are characterized by higher prevalence of seropositivity to virus and bacterial agents in comparison with general population. Moreover, these agents may infect salivary gland epithelial cells. Stronger evidence confirmed the role of some viruses, like Epstein\u2013Barr, as triggers of the disease and different mechanisms have been demonstrated to interplay. Recent experimental and clinical studies supported the adjunctive role of an altered buccal and intestinal microbial composition and chronic inflammatory response to <jats:italic toggle=\"yes\">Helicobacter pylori<\/jats:italic> in disease induction. Finally, latent viral infections and immune system chronic stimulation induced by persistent infections may participate in disease lymphoproliferative evolution.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Different viral and bacterial agents have been identified as triggers in Sj\u00f6gren's syndrome induction and contributors to the chronic immune system stimulation underlying lymphoproliferative complication. Deeper knowledge of involved microbial agents and pathogenic mechanisms linking Sj\u00f6gren's syndrome and infections may help the identification of preventive therapeutic strategy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000631","type":"journal-article","created":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T03:15:54Z","timestamp":1558754154000},"page":"505-511","source":"Crossref","is-referenced-by-count":20,"title":["The dark side of Sj\u00f6gren's syndrome: the possible pathogenic role of infections"],"prefix":"10.1097","volume":"31","author":[{"given":"Elena","family":"Bartoloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Alunno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"(Suppl. 112)","key":"R1-20230829","first-page":"14","article-title":"One year in review 2018: Sj\u00f6gren's syndrome","volume":"36","author":"Argyropoulou","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s13317-016-0086-x","article-title":"Infections as cause of autoimmune rheumatic diseases","volume":"7","author":"Sakkas","year":"2016","journal-title":"Auto Immun Highlights"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/1744666X.2018.1519396","article-title":"Interferon activation in primary Sj\u00f6gren's syndrome: recent insights and future perspective as novel treatment target","volume":"14","author":"Bodewes","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0000000000000524","article-title":"An update on the role of type I interferons in systemic lupus erythematosus and Sj\u00f6gren's syndrome","volume":"30","author":"Thorlacius","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"1246818","DOI":"10.1155\/2018\/1246818","article-title":"Current and emerging evidence for Toll-like receptor activation in Sj\u00f6gren's syndrome","volume":"2018","author":"Kiripolsky","year":"2018","journal-title":"J Immunol Res"},{"key":"R6-20230829","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12888","article-title":"Infections increase the risk of developing Sj\u00f6gren's syndrome","author":"Mofors","year":"2019","journal-title":"J Intern Med"},{"key":"R7-20230829","first-page":"929","article-title":"The interaction between anti-Ro\/SSA and anti-La\/SSB autoantibodies and antiinfectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic","volume":"35","author":"Agmon-Levin","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2014.02.008","article-title":"Infection and autoimmunity in Sj\u00f6gren's syndrome: a clinical study and comprehensive review","volume":"51","author":"Kivity","year":"2014","journal-title":"J Autoimmun"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1573397112666160714164149","article-title":"Update on pathogenesis of Sj\u00f6gren's syndrome","volume":"13","author":"Sandhya","year":"2017","journal-title":"Curr Rheumatol Rev"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38726","article-title":"Implication of Epstein\u2013Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj\u00f6gren's syndrome","volume":"66","author":"Croia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00296-012-2504-3","article-title":"EBV reactivation serological profile in primary Sj\u00f6gren's syndrome: an underlying trigger of active articular involvement?","volume":"33","author":"Pasoto","year":"2013","journal-title":"Rheumatol Int"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365513.2018.1550807","article-title":"Increased antibody levels to stage-specific Epstein\u2013Barr virus antigens in systemic autoimmune diseases reveal a common pathology","volume":"79","author":"Sternbaek","year":"2019","journal-title":"Scand J Lab Clin Invest"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"8567364","DOI":"10.1155\/2019\/8567364","article-title":"Microbial agents as putative inducers of B cell lymphoma in Sj\u00f6gren's syndrome through an impaired epigenetic control: the State-of-The-Art","volume":"2019","author":"Talotta","year":"2019","journal-title":"J Immunol Res"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4049\/jimmunol.1701272","article-title":"The chemokine receptor CXCR3 promotes CD8+ T Cell accumulation in uninfected salivary glands but is not necessary after murine cytomegalovirus infection","volume":"200","author":"Caldeira-Dantas","year":"2018","journal-title":"J Immunol"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/BOR.0000000000000287","article-title":"What is the evidence for Sj\u00f6gren's syndrome being triggered by viral infection? Subplot: infections that cause clinical features of Sj\u00f6gren's syndrome","volume":"28","author":"Nakamura","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R17-20230829","first-page":"S51","article-title":"Detection of human T lymphotropic virus type-I bZIP factor and tax in the salivary glands of Sj\u00f6gren's syndrome patients","volume":"36","author":"Nakamura","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"2075803","DOI":"10.1155\/2019\/2075803","article-title":"Sj\u00f6gren's syndrome: concerted triggering of sicca conditions","volume":"2019","author":"Mackiewicz","year":"2019","journal-title":"J Immunol Res"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/BOR.0b013e32836200d2","article-title":"Autoimmunity and infection in Sj\u00f6gren's syndrome","volume":"25","author":"Igoe","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"e0161958","DOI":"10.1371\/journal.pone.0161958","article-title":"Association of Sj\u00f6gren's syndrome in patients with chronic hepatitis virus infection: a population-based analysis","volume":"11","author":"Yeh","year":"2016","journal-title":"PLoS One"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/rheumatology\/key215","article-title":"Dysbiosis of the buccal mucosa microbiome in primary Sj\u00f6gren's syndrome patients","volume":"57","author":"van der Meulen","year":"2018","journal-title":"Rheumatology"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2018.10.009","article-title":"Shared gut, but distinct oral microbiota composition in primary Sj\u00f6gren's syndrome and systemic lupus erythematosus","volume":"97","author":"van der Meulen","year":"2019","journal-title":"J Autoimmun"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10067-017-3821-4","article-title":"The role of gut microbiota in the pathogenesis of rheumatic diseases","volume":"37","author":"Zhong","year":"2018","journal-title":"Clin Rheumatol"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3389\/fimmu.2018.01106","article-title":"Current insights in microbiome shifts in Sj\u00f6gren's syndrome and possible therapeutic interventions","volume":"9","author":"Tsigalou","year":"2018","journal-title":"Front Immunol"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/cei.13158","article-title":"The microbiome in autoimmune diseases","volume":"195","author":"De Luca","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13075-017-1446-2","article-title":"Severe intestinal dysbiosis is prevalent in primary Sj\u00f6gren's syndrome and is associated with systemic disease activity","volume":"19","author":"Mandl","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/joim.12631","article-title":"The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study","volume":"282","author":"Baldini","year":"2017","journal-title":"J Intern Med"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0961203314559634","article-title":"Mycobacteria and autoimmunity","volume":"24","author":"Ribeiro","year":"2015","journal-title":"Lupus"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"e0176549","DOI":"10.1371\/journal.pone.0176549","article-title":"Association between a history of mycobacterial infection and the risk of newly diagnosed Sj\u00f6gren's syndrome: a nationwide, population-based case\u2013control study","volume":"12","author":"Chao","year":"2017","journal-title":"PLoS One"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"12839","DOI":"10.3748\/wjg.v20.i36.12839","article-title":"Role of Helicobacter pylori infection in autoimmune systemic rheumatic diseases","volume":"20","author":"Radi\u0107","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3748\/wjg.v20.i3.613","article-title":"Helicobacter pylori and autoimmune disease: cause or bystander","volume":"20","author":"Smyk","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"e13528","DOI":"10.1097\/MD.0000000000013528","article-title":"Association between Helicobacter pylori infection and Sj\u00f6gren syndrome: a meta-analysis","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine"},{"key":"R33-20230829","article-title":"Helicobacter pylori infection in Sj\u00f6gren's syndrome: co-incidence or causality?","author":"Saghafi","year":"2018","journal-title":"Curr Rheumatol Rev"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcimb.2017.00185","article-title":"Deregulation of microRNAs in gastric lymphomagenesis induced in the d3Tx mouse model of Helicobacter pylori infection","volume":"7","author":"Floch","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"R35-20230829","first-page":"616","article-title":"Anti-Saccharomyces cerevisiae autoantibodies and autoimmune diseases: the sweet and sour of baking yeast","volume":"16","author":"Rinaldi","year":"2014","journal-title":"IMAJ"},{"key":"R36-20230829","first-page":"S73","article-title":"Prevalence and significance of anti-Saccharomyces cerevisiae antibodies in primary Sj\u00f6gren's syndrome","volume":"36","author":"Alunno","year":"2018","journal-title":"Clin Exp Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:06:59Z","timestamp":1693292819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000631","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}